News
Looking into the current session, Pfizer Inc. (PFE) shares are trading at $25.84, after a 0.39% increase. Moreover, over the ...
Construction work paused at 235 East 42nd Street, David Werner and Metro Loft’s massive office-to-resi conversion in Midtown ...
23h
Zacks Investment Research on MSNPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
The trend in the state is consistent with an uptick in several parts of the country, including New York and California.
Pfizer faces challenges from pricing pressures, a 2026 patent cliff, and weak R&D momentum. Click here to find out why I rate ...
The market offers significant opportunities driven by increasing demand for personalized therapies, especially in oncology and rare diseases. Targete ...
Pfizer is making significant strides in the oncology sector, boasting a robust lineup of cancer treatments. Its oncology ...
3d
TipRanks on MSNWhy Pfizer’s (PFE) Oncology Gamble is Finally Paying Off
Pfizer ($PFE) may finally be turning the corner on its post-pandemic revenue challenges. The company recently reported ...
Pigot most recently served as chief commercial officer at Aerovate Therapeutics, which was developing a dry powder inhaled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results